| Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. | |
| | |
MedLine Citation:
|
PMID: 16148439 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The present article focuses on psychoneuroendocrine effects of cannabinoids in developing animals, with special emphasis on the perinatal, periweanling and periadolescent periods. We describe and discuss published data dealing with acute and long-term effects of exposure to cannabinoid agonists in such critical periods. Human studies have demonstrated that the consumption of marijuana by women during pregnancy affects the neurobehavioural development of their children. Investigations using animal models provide useful information for a better understanding of the long-lasting deleterious consequences of cannabis exposure during pregnancy and lactation. The increasing use of cannabis among adolescents and its associated public health problems have led to a parallel increase in basic research on appropriate animal models. Chronic administration of cannabinoid agonists during the periadolescent period causes persistent behavioural alterations in adult animals. Some of these alterations may be related to a possible increased risk of psychosis and other neuropsychiatric disorders in early onset cannabis users. |
| | |
Authors:
|
M P Viveros; R Llorente; E Moreno; E M Marco |
Related Documents
:
|
7488569 - Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsa... 7189979 - Developmental toxicity of methoxyflurane in mice. 12056499 - Fetal alcohol syndrome--alaska, arizona, colorado, and new york, 1995-1997. 7847599 - Screening for pregnancy risk-drinking. 8947939 - Prenatal cocaine exposure: effects on the development of school-age children. 15380829 - Cocaine-induced inhibition of process outgrowth in locus coeruleus neurons: role of ges... 12797149 - Fetal umbilical cord ligation under ultrasound guidance. 9914619 - A role for estriol in human labor, term and preterm. 457979 - Pregnancy rate in dairy cows inseminated on the basis of electronic probe measurements. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Behavioural pharmacology Volume: 16 ISSN: 0955-8810 ISO Abbreviation: Behav Pharmacol Publication Date: 2005 Sep |
Date Detail:
|
Created Date: 2005-09-08 Completed Date: 2006-01-09 Revised Date: 2009-07-07 |
Medline Journal Info:
|
Nlm Unique ID: 9013016 Medline TA: Behav Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 353-62 Citation Subset: IM |
Affiliation:
|
Departamento de Fisiología (Fisiología Animal II), Facultad de Biología, Universidad Complutense, Madrid, Spain. pazviver@bio.ucm.es |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Behavior, Animal / drug effects*, physiology Benzoxazines Brain / drug effects, growth & development, physiology Cannabinoids / pharmacology* Critical Period (Psychology) Cyclohexanols / pharmacology Morpholines / pharmacology Naphthalenes / pharmacology Neurosecretory Systems / drug effects*, physiology Tetrahydrocannabinol / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Benzoxazines; 0/Cannabinoids; 0/Cyclohexanols; 0/Morpholines; 0/Naphthalenes; 134959-51-6/Win 55212-2; 1972-08-3/Tetrahydrocannabinol; 83003-12-7/3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depressi...
Next Document: SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.